Confirmant Ltd. Appoints Scientific Advisory Board
Monday March 10, 2:08 pm ET
ABINGDON, England, March 10 /PRNewswire/ -- Confirmant Ltd., a provider of protein-centric bio-information, announced today the newly elected members of its Scientific Advisory Board (SAB).
The recently formed SAB is comprised of well-established, influential leaders in the fields of Bioinformatics, Functional Genomics and Computational Biology respectively. Namely: Graham Cameron -- Associate Director of the EBI, Cambridge; Dr. Duncan Campbell -- Director of the MRC HGMP Resource Centre, Wellcome Trust Genome Campus, Cambridge and Dr. Michael Liebman -- Director, Computational Biology and Biomedical Informatics at the Abramson Cancer Center of the University of Pennsylvania, and Adjunct Professor of Cancer Biology.
ADVERTISEMENT
Dr. Jonathan Sheldon, Confirmant's Chief Technology Officer, is delighted with the selection and adds, "The wealth of experience contained within our SAB will ensure that Confirmant's scientific direction remains on track and that the Protein Atlas of the human genome will continue to evolve and enable a higher rate of success in the research and development of new drugs."
The SAB member's experience encompasses a wide variety of knowledge:
Prior to his current position as Associate Director of the European Bioinformatics Institute (EBI), Graham Cameron was joint head of the EBI and was responsible for its launch in 1993. He ran the Information Services sector of the EBI until 1998. Graham also worked with EMBL-Heidelberg in the DNA Data Library, for both software and database design, leading the project from 1986. Graham holds a degree and has conducted post-graduate research in Psychology and Computer Science.
Dr. Michael Liebman is also Chief Scientific Officer for ProSanos. Recently, Michael served as Global Head of Computational Genetics for Roche Bioscience. Formerly, he was Director of Biomedical Informatics and Pharmacogenomics at Wyeth-Ayerst Research, where he had the responsibility for the development of Biomedical Informatics. Prior to this he was a Director of Bioinformatics and Genomics at Vysis, following eight years at Amoco as Manager of Bioinformatics. His area of research focuses on the modeling of disease processes in cancer, integrating clinical data into bioinformatic analysis. His PhD is in Physical Chemistry and Protein Crystallography from Michigan State University.
Prior to moving to Cambridge, Dr. Duncan Campbell was a Senior Scientist in the MRC Immunochemistry Unit in the Biochemistry Department at Oxford University between 1980 and 1998, and during that time also held research Fellowships from Wolfson and Green Colleges. He is an expert in the identification of human genes, the functional characterisation of their protein products, and how they may contribute to autoimmune/infectious disease susceptibility. His work in this area was recognised in 2001, when he was elected a Fellow of the Academy of Medical Sciences. Dr. Campbell holds a PhD in biochemistry from the University of Aberdeen and a biochemistry degree from the University of Glasgow.
"This is an exciting time for us," Dr Sheldon summarises. "We look forward to incorporating the SAB feedback into the future direction of our products and services."
About Confirmant
Confirmant Ltd. will provide novel and unique post-genomic bio-information to the pharmaceutical, biotechnology and medical research communities. Based on experimentally derived human protein sequence determination, Confirmant's first database product, the Protein Atlas of the Human Genome, will be the first definitive database of human proteins, their variants and genes encoding for them. This information will more reliably aid in the identification and validation of drug targets and disease biomarkers, resulting in faster and more effective development of new treatments and diagnostics. Confirmant is a joint venture between Oxford GlycoSciences (LSE: OGS - News; Nasdaq: OGSI - News) and Marconi (MONI) and is based in Abingdon in the United Kingdom.
CONTACT: UK Contact, Martin Gouldstone of Confirmant Ltd., +44-1235-208-190, or martin.gouldstone@confirmant.com; or USA Contact, Geraldine Floresca of Neale-May & Partners, +1-415-646-0055, ext. 501, or gfloresca@nealemay.com, for Confirmant Ltd.
--------------------------------------------------------------------------------
Source: Confirmant Ltd. |
